Recent 13F filings as of September 2025 show that 102 institutional investors hold a position in Aclaris Therapeutics, Inc. (NASDAQ:ACRS).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 30 Sep, 2025 | 14,250,000 | 0 | 0.00% | $27,075,000.00 |
| Vivo Capital, LLC | 30 Sep, 2025 | 8,888,888 | 0 | 0.00% | $16,888,887.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 6,515,458 | -146,605 | -2.20% | $12,379,370.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 5,691,352 | 176,473 | 3.20% | $10,813,569.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 30 Sep, 2025 | 5,278,144 | -4,349,160 | -45.18% | $10,028,474.00 |
| Rock Springs Capital Management LP | 30 Sep, 2025 | 4,609,309 | -160,000 | -3.35% | $8,757,687.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 4,077,246 | 537,054 | 15.17% | $7,746,768.00 |
| Decheng Capital LLC | 30 Sep, 2025 | 4,041,736 | 0 | 0.00% | $7,679,298.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 2,389,531 | -75,248 | -3.05% | $4,541,475.00 |
| D. E. Shaw & Co., Inc. | 30 Sep, 2025 | 2,373,226 | -427,056 | -15.25% | $4,509,129.00 |
| ACADIAN ASSET MANAGEMENT LLC | 30 Sep, 2025 | 2,327,019 | -106,831 | -4.39% | $4,417.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 1,718,130 | -574,319 | -25.05% | $3,264,447.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 1,619,731 | 154,953 | 10.58% | $3,077,489.00 |
| Palo Alto Investors LP | 30 Sep, 2025 | 1,566,840 | 176,812 | 12.72% | $2,976,996.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 1,554,458 | -2,282,922 | -59.49% | $2,953,470.00 |
| Logos Global Management LP | 30 Sep, 2025 | 1,500,000 | -350,000 | -18.92% | $2,850,000.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 1,432,677 | 310,596 | 27.68% | $2,722,086.00 |
| AMERIPRISE FINANCIAL INC | 30 Sep, 2025 | 1,277,817 | 1,214,843 | 1,929.12% | $2,427,852.00 |
| Bollard Group LLC | 30 Sep, 2025 | 1,225,476 | 1,225,476 | 0.00% | $2,328.00 |
| STATE STREET CORP | 30 Sep, 2025 | 1,113,146 | 106,253 | 10.55% | $2,114,977.00 |